• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂对头颈部癌改变分割方案中作用的随机模型。

Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer.

机构信息

University of Adelaide, School of Chemistry and Physics, Australia.

出版信息

Phys Med. 2010 Oct;26(4):177-83. doi: 10.1016/j.ejmp.2009.11.004. Epub 2010 Jan 14.

DOI:10.1016/j.ejmp.2009.11.004
PMID:20034829
Abstract

Advanced head and neck cancers are one of the most challenging cancers facing the oncologists due to their aggressiveness attributable to the high hypoxic content and the tumour's ability to repopulate during radiotherapy. Alterations of radiotherapy fractionation schedules are possible ways to improve tumour control. Clinical trials have shown that both hyperfractionated radiotherapy (multiple fractions a day, over the same treatment time), and accelerated radiotherapy (higher doses per fraction, six days a week, over 5 weeks or less) are more effective than conventional radiotherapy in the management of head and neck cancer. However, the treatment choice between hyperfractionated and accelerated radiotherapy is still debated, due to very similar results obtained regarding tumour control. Furthermore, while radiotherapy alone has an impact on the short-term prognosis of advanced head and neck cancer, the long-term benefits have been moderate. Cisplatin is a chemotherapeutic agent which combined with conventional radiotherapy has shown to improve patient survival. The present paper employs a Monte Carlo modelling approach in assessing the effect of combined cisplatin-altered fractionation schedule on tumour response. The growth of a head and neck carcinoma has been modelled using probabilistic functions sampled by computer generated random number sequences, maintaining the biological constitution of a tumour. The tumour growth model has been built to simulate the in vivo processes taking place before and after radiotherapy/chemotherapy. The model has shown that adding cisplatin to radiotherapy improves tumour control in both hyperfractionated and accelerated radiotherapy.

摘要

晚期头颈部癌症是肿瘤学家面临的最具挑战性的癌症之一,由于其侵袭性归因于高缺氧含量和肿瘤在放疗期间重新增殖的能力。改变放疗分割方案是提高肿瘤控制的可能方法。临床试验表明,超分割放疗(每天多次分割,在相同的治疗时间内)和加速放疗(每周 6 天,每天更高剂量,5 周或更短时间内)在头颈部癌症的治疗中比常规放疗更有效。然而,由于在肿瘤控制方面取得了非常相似的结果,超分割和加速放疗之间的治疗选择仍存在争议。此外,虽然单独放疗对头颈部晚期癌症的短期预后有影响,但长期获益适中。顺铂是一种化疗药物,与常规放疗联合使用已显示可提高患者生存率。本文采用蒙特卡罗建模方法评估联合顺铂改变分割方案对肿瘤反应的影响。头颈部癌的生长采用通过计算机生成的随机数序列采样的概率函数进行建模,保持肿瘤的生物学构成。肿瘤生长模型被构建为模拟放疗/化疗前后发生的体内过程。该模型表明,在超分割和加速放疗中,顺铂联合放疗可改善肿瘤控制。

相似文献

1
Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer.顺铂对头颈部癌改变分割方案中作用的随机模型。
Phys Med. 2010 Oct;26(4):177-83. doi: 10.1016/j.ejmp.2009.11.004. Epub 2010 Jan 14.
2
Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.同步使用顺铂可显著提高晚期头颈癌超分割放疗的局部区域控制率。
J Clin Oncol. 2004 Dec 1;22(23):4665-73. doi: 10.1200/JCO.2004.12.193. Epub 2004 Nov 8.
3
Neoadjuvant cisplatin for head and neck cancer: Simulation of a novel schedule for improved therapeutic ratio.头颈部癌症的新辅助顺铂治疗:模拟一种新方案以提高治疗比率。
J Theor Biol. 2012 Mar 21;297:41-7. doi: 10.1016/j.jtbi.2011.12.001. Epub 2011 Dec 13.
4
A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.头颈部未切除局部晚期鳞状细胞癌超分割与加速放疗及放化疗联合方案的荟萃分析
BMC Cancer. 2006 Jan 31;6:28. doi: 10.1186/1471-2407-6-28.
5
Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.顺铂和紫杉醇同步进行的积极放化疗联合加速超分割放疗用于局部晚期头颈部肿瘤。一项I-II期试验的结果
Strahlenther Onkol. 2003 Oct;179(10):673-81. doi: 10.1007/s00066-003-1106-0.
6
Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.晚期头颈癌患者的分割疗程超分割加速放化疗(SCHARC):方案偏差和血红蛋白对总生存的影响,一项回顾性分析
BMC Cancer. 2006 Dec 7;6:279. doi: 10.1186/1471-2407-6-279.
7
Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.局部晚期头颈癌的超分割放疗联合或不联合同步化疗
N Engl J Med. 1998 Jun 18;338(25):1798-804. doi: 10.1056/NEJM199806183382503.
8
The role of amifostine in the treatment of head and neck cancer with cisplatin-radiotherapy.氨磷汀在顺铂联合放疗治疗头颈部癌中的作用。
Eur J Cancer Care (Engl). 2009 Mar;18(2):116-23. doi: 10.1111/j.1365-2354.2008.01032.x.
9
Scheduling cisplatin and radiotherapy in the treatment of squamous cell carcinomas of the head and neck: a modelling approach.顺铂与放疗联合治疗头颈部鳞状细胞癌的时间安排:一种建模方法。
Phys Med Biol. 2006 Aug 7;51(15):3625-37. doi: 10.1088/0031-9155/51/15/002. Epub 2006 Jul 12.
10
Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.同步化疗加超分割加速放疗对晚期头颈部鳞状细胞癌的影响。
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1088-95. doi: 10.1016/j.ijrobp.2008.05.042. Epub 2008 Aug 15.

引用本文的文献

1
New potential for enhancing concomitant chemoradiotherapy with FDA approved concentrations of cisplatin via the photoelectric effect.通过光电效应以美国食品药品监督管理局(FDA)批准的顺铂浓度增强同步放化疗的新潜力。
Phys Med. 2015 Feb;31(1):25-30. doi: 10.1016/j.ejmp.2014.11.004. Epub 2014 Dec 6.